Potential
dilutive securities are excluded from the calculation of diluted EPS in loss periods as their effect would be anti-dilutive.
Schedule
of basic and diluted net loss per share
| | |
| | | |
| | |
| | |
For the Three Months Ended December 31, | |
| | |
2025 | | |
2024 | |
| Statement of Operations Summary Information: | |
| | | |
| | |
| Net loss from continued operation | |
$ | (28,618 | ) | |
$ | (457,740 | ) |
| Weighted- average common shares outstanding – basic and diluted | |
| 2,081,643 | | |
| 115,934 | |
| Net loss per share, basic and diluted from continued operation | |
$ | (0.01 | ) | |
$ | (3.95 | ) |
| Net loss from discontinued operation | |
$ | - | | |
$ | (145,957 | ) |
| Weighted- average common shares outstanding – basic and diluted | |
| - | | |
| 115,934 | |
| Net loss per share, basic and diluted from continued operation | |
$ | - | | |
$ | (1.26 | ) |
|